← Eichor
Study identifier: NCT06625060 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults

Condition: Episodic Migraine · Chronic Migraine  ·  Sponsor: Ipsen

PhasePhase 2
Planned participants641
Who can joinAll sexes, 18 Years to 80 Years
Healthy volunteersNo

About this study

A migraine is a headache with severe throbbing pain or a pulsating sensation, usually on one side of the head. It is often accompanied by feeling or being sick and a sensitivity to bright lights and sound. Migraines are caused by a series of events when the brain gets stimulated or activated, which causes the release of chemicals that cause pain. Corabotase (also known as IPN10200) is a medication that stops the release of these chemical messengers. Participants with episodic migraine (EM) or chronic migraine (CM) will be included in both Step 1 and Step 2. "Headache days" are when participants experience headaches that meet the criteria for a migraine or a headache without the additional migraine-specific symptoms. "Migraine days" occur when the headache displays clear migraine characteristics. This study aims to determine: * The safety and efficacy of injecting Corabotase directly into the muscles of the head and neck to prevent EM and CM, * The right amount (dose) of Corabotase to inject at each point, * The total amount (dose) of Corabotase that provides the best balance between safety and efficacy preventing migraines. Participants will need to complete a daily electronic migraine Diary (eDiary) and questionnaires throughout the study. The total study duration for a participant will be up to 44 weeks.

This description comes directly from the study's public registry record.

Talk to the study team

Ipsen Clinical Study Enquiries  ·  See e mail  ·  clinical.trials@ipsen.com

Always discuss trial participation with your own doctor first.

Locations (166)

Central Research AssociatesBirmingham, Alabama, United StatesNot Yet Recruiting
Rehabilitation & Neurological Services, LLCHuntsville, Alabama, United StatesRecruiting
MD First Research - Chandler - NeurologyChandler, Arizona, United StatesRecruiting
MD First Research - ChandlerChandler, Arizona, United StatesRecruiting
Baptist Health Center for Clinical ResearchLittle Rock, Arkansas, United StatesWithdrawn
Axiom Research, LLCApple Valley, California, United StatesNot Yet Recruiting
Profound Research. LLC - NCSCCarlsbad, California, United StatesRecruiting
M3Wake -PRI EncinoEncino, California, United StatesRecruiting
WR-PRI EncinoEncino, California, United StatesRecruiting
Neuro-Pain Medical CenterFresno, California, United StatesRecruiting
Fullerton Neurological Center - NeurologyFullerton, California, United StatesRecruiting
Neurology Center of North Orange CountyFullerton, California, United StatesNot Yet Recruiting

+ 154 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06625060